|
projekti nr |
akronüüm ja pealkiri |
kestus |
H2020 - 951724
|
B1MG - Beyond 1M Genomes |
2020-2023 |
H2020 - 825303
|
Bergamot - Browser-based Multilingual Translation |
- |
H2020 - 777389
|
c4c - conect4children (COllaborative Network for European Clinical Trials For Children) |
2018-2024 |
H2020 - 765224
|
FATIGUE - Delayed Transformational Fatigue in Central and Eastern Europe |
2018-2021 |
H2020 - 874864
|
HEDIMED - Human Exposomic Determinants of Immune Mediated Diseases |
2020-2024 |
H2020 - 871106
|
ISABEL - Improving the sustainability of the European Magnetic Field Laboratory |
2020-2024 |
H2020 - 822682
|
POPREBEL - Populist rebellion against modernity in 21st-century Eastern Europe: neo-traditionalism and neo-feudalism |
2019-2021 |
FP7 - 242204
|
AAA-PREVENT - Effective Environmental Strategies for the Prevention of Alcohol Abuse among Adolescents in Europe |
2010-2012 |
FP7 - 223692
|
CHERISH - Improving Diagnoses of Mental Retardation in Children in Central Eastern Europe and Central Asia through Genetic Characterisation and Bioinformatics/-Statistics, |
2009-2012 |
FP7 - 212230
|
CLARIN - Common Language Resources and Technology Infrastructure |
2008-2011 |
FP7 - 602453
|
CloSed - Clonidine for Sedation of Paediatric Patients in the Paediatric Intensive Care Unit |
2013-2018 |
FP7 - 244749
|
ESTABLISH - European Science and Technology in Action Building Links with Industry, Schools and Home |
2010-2013 |
FP7 - 262549
|
IATS - Development of an innovative, completely automated antifouling test system for professional examinations of marine coatings |
2011-2013 |
FP7 - 201230
|
RAREDISEASEPLATFORM - A European Platform of Integrated Information Services for Researchers in the Field of Rare Diseases and Orphan Drugs Supporting Team and Project Building. |
2008-2011 |
FP7 - 226852
|
SCALES - Securing the Conservation of biodiversity across Administrative Levels and spatial, temporal, and Ecological Scales |
2009-2014 |
FP7 - 223143
|
TECHGENE - High throughput molecular diagnostics in individual patients for genetic diseases with heterogeneous clinical presentation |
2009-2012 |
|
|